Work

Evaluating clinical responses to BRAF inhibition in BRAF/TERT promoter mutated melanoma.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.e21551

Authors: Colleen Ciccosanti, Alexander Hershey, Chunxia Chen, Dirk F. Moore, Ryan D. Stephenson, Joseph P. Weiner, Vadim P. Koshenkov, Ann W. Silk, Janice M. Mehnert, Adam C. Berger, Roman Groisberg

Institutions: Rutgers, The State University of New Jersey, Rutgers Cancer Institute, Memorial Sloan Kettering Cancer Center, New York University

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3169638314

Cites:

Cited by:

Related to: 10